Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system

Authors

Siwen Li, China Pharmaceutical University
Yuxi Liu, China Pharmaceutical University
Yalan Rui, China Pharmaceutical University
Liping Tang, University of Texas at Arlington
Samuel Achilefu, Washington University School of Medicine in St. Louis
Yueqiing Gu, China Pharmaceutical University

Journal

Theranostics

Publication Date

2018

Volume

8

Issue

10

Inclusive Pages

2621-2633

Document Type

Open Access Publication

DOI

10.7150/thno.24469

Rights and Permissions

Li S, Liu Y, Rui Y, Tang L, Achilefu S, Gu Y. Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system. Theranostics 2018; 8(10):2621-2633. doi:10.7150/thno.24469. Available from http://www.thno.org/v08p2621.htm This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.

Recommended Citation

Li, Siwen; Liu, Yuxi; Rui, Yalan; Tang, Liping; Achilefu, Samuel; and Gu, Yueqiing, "Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system." Theranostics. 8, 10. 2621-2633. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7794